AGPAT2 antibody (AA 199-278)
Quick Overview for AGPAT2 antibody (AA 199-278) (ABIN6136640)
Target
See all AGPAT2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 199-278
-
Sequence
- IVPVVYSSFS SFYNTKKKFF TSGTVTVQVL EAIPTSGLTA ADVPALVDTC HRAMRTTFLH ISKTPQENGA TAGSGVQPAQ
-
Cross-Reactivity
- Human, Mouse
-
Characteristics
- Polyclonal Antibodies
-
Purification
- Affinity purification
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 199-278 of human AGPAT2 (NP_006403.2).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:500 - 1:2000,IF,1:50 - 1:100
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2))
-
Alternative Name
- AGPAT2
-
Background
- This gene encodes a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in this gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.,AGPAT2,1-AGPAT2,BSCL,BSCL1,LPAAB,LPAAT-beta,Cancer,Endocrine & Metabolism,Lipid Metabolism,Cardiovascular,Lipids,Fatty Acids,AGPAT2
-
Molecular Weight
- 27 kDa/30 kDa
-
Gene ID
- 10555
-
UniProt
- O15120
Target
-